Theseus Pharmaceuticals, Inc.
NASDAQ:THRX
4.065 (USD) • At close February 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 46.893 | 47.465 | 109.698 | 94.605 | 115.564 | 135.091 | 146.281 | 244.662 | 90.404 | 97.586 | 8.457 |
| Short Term Investments
| 158.229 | 160.74 | 126.936 | 103.374 | 96.87 | 89.704 | 85.757 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 205.122 | 208.205 | 236.634 | 197.979 | 212.434 | 224.795 | 232.038 | 244.662 | 90.404 | 97.586 | 8.457 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.464 | 5.548 | 5.763 | 4.137 | 2.563 | 2.722 | 2.914 | 3.309 | 1.082 | 1.739 | 0.113 |
| Total Current Assets
| 209.586 | 213.753 | 236.634 | 197.979 | 214.997 | 227.517 | 234.952 | 247.971 | 91.486 | 99.325 | 8.57 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 4.334 | 4.497 | 4.605 | 4.75 | 4.89 | 4.976 | 4.758 | 0.011 | 0 | 0 | 0.001 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 20.308 | 26.027 | 6.979 | 13.817 | 8.541 | 3.807 | 4.945 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.399 | 0.794 | 7.402 | 5.901 | 1.865 | 1.989 | 2.85 | 2.947 | 6.133 | 2.745 | 0.043 |
| Total Non-Current Assets
| 25.041 | 31.318 | 18.986 | 24.468 | 15.296 | 10.772 | 12.553 | 2.958 | 6.133 | 2.745 | 0.044 |
| Total Assets
| 234.627 | 245.071 | 255.62 | 222.447 | 230.293 | 238.289 | 247.505 | 250.929 | 97.619 | 102.07 | 8.614 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 1.313 | 2.415 | 2.185 | 4.973 | 1.819 | 1.505 | 1.425 | 1.002 | 2.392 | 1.766 | 1.132 |
| Short Term Debt
| 0.759 | 0.754 | 0.748 | 0.743 | 0.779 | 0.774 | 1.179 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 4.582 | 4.164 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 0.349 | 0.349 | 3.691 | 5.414 | 5.208 | 2.932 | 2.779 | 2.678 | 3.288 | 2.2 | 0.463 |
| Total Current Liabilities
| 7.003 | 7.682 | 6.624 | 11.13 | 7.806 | 5.211 | 5.383 | 3.68 | 5.68 | 3.966 | 1.595 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 2.897 | 3.014 | 3.129 | 3.236 | 3.34 | 3.442 | 3.542 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.205 | 0.292 | 0.379 | 0.466 | 0.553 | 0.641 | 0.728 | 0.815 | 142.084 | 142.17 | 41.289 |
| Total Non-Current Liabilities
| 3.102 | 3.306 | 3.508 | 3.702 | 3.893 | 4.083 | 4.27 | 0.815 | 142.084 | 142.17 | 41.289 |
| Total Liabilities
| 10.105 | 10.988 | 10.132 | 14.832 | 11.699 | 9.294 | 9.653 | 4.495 | 147.764 | 146.136 | 42.884 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41.289 | 0 | 0 |
| Common Stock
| 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0 | 0 | 0 |
| Retained Earnings
| -155.081 | -141.577 | -126.772 | -112.186 | -98.469 | -83.724 | -72.075 | -61.578 | -52.922 | -45.55 | -34.27 |
| Accumulated Other Comprehensive Income/Loss
| -0.345 | -0.561 | -0.159 | -0.386 | -0.55 | -0.332 | -0.129 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 379.944 | 376.217 | 372.415 | 320.183 | 317.609 | 313.047 | 310.052 | 308.008 | -38.512 | 1.484 | 0 |
| Total Shareholders Equity
| 224.522 | 234.083 | 245.488 | 207.615 | 218.594 | 228.995 | 237.852 | 246.434 | -50.145 | -44.066 | -34.27 |
| Total Equity
| 224.522 | 234.083 | 245.488 | 207.615 | 218.594 | 228.995 | 237.852 | 246.434 | -50.145 | -44.066 | -34.27 |
| Total Liabilities & Shareholders Equity
| 234.627 | 245.071 | 255.62 | 222.447 | 230.293 | 238.289 | 247.505 | 250.929 | 97.619 | 102.07 | 8.614 |